Outdated criteria for drug plan reimbursement obstruct evidence-based care
- PMID: 35040803
- PMCID: PMC8568076
- DOI: 10.1503/cmaj.211617
Outdated criteria for drug plan reimbursement obstruct evidence-based care
Conflict of interest statement
Competing interests: Ahmed Bayoumi is a member of the Canadian Drug Expert Committee. His term concludes in September 2021. He has received grants (paid to his institution) from the Canadian Institutes of Health Research, St. Michael’s Hospital Foundation, Canadian Research Initiative in Substance Misuse, Mitacs and University of Toronto. See www.cmaj.ca/site/misc/cmaj_staff.xhtml for Andreas Laupacis.
Comment on
-
Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer.CMAJ. 2021 Oct 12;193(40):E1551-E1560. doi: 10.1503/cmaj.210523. CMAJ. 2021. PMID: 35040802 Free PMC article.
-
Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study.CMAJ. 2021 Oct 12;193(40):E1561-E1567. doi: 10.1503/cmaj.210811. CMAJ. 2021. PMID: 35040805 Free PMC article.
References
-
- Atrial fibrillation: diagnosis and management. London (UK): National Institute for Health and Care Excellence; 2021. Available: https://www.nice.org.uk/guidance/ng196 (accessed 2021 Sept. 13).
-
- Alberta Drug Benefit List. Edmonton: Alberta Blue Cross/Alberta Health; 2021. Available: https://www.ab.bluecross.ca/dbl/pdfs/dbl_full_list.pdf (accessed 2021 Sept. 13).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical